The
Protein 4.1 family contains at least two members that function as tumour suppressors, the
neurofibromatosis 2 gene product merlin and the recently identified differentially expressed in
adenocarcinoma of the lung (DAL-1)/
Protein 4.1B molecule. DAL-1/
Protein 4.1B loss is observed in a variety of tumours, including breast and
lung cancers as well as
meningiomas. We have previously demonstrated that DAL-1/
Protein 4.1B interacts with some but not all
merlin-
binding proteins, raising the possibility that DAL-1/
Protein 4.1B associates with additional unique
proteins specific to its function as a negative growth regulator. Using yeast two-hybrid interaction cloning, we identified three 14-3-3
isoforms, beta, gamma and eta, to be DAL-1/
Protein 4.1B-binding
proteins. These interactions were verified by using
glutathione S-transferase affinity chromatography in vitro and co-immunoprecipitation in vivo. The interaction of 14-3-3 with DAL-1/
Protein 4.1B was specific, as 14-3-3 did not bind to the related
Protein 4.1 family members
merlin,
ezrin or
radixin. The DAL-1/
Protein 4.1B domain that mediates 14-3-3 binding was mapped to residues Pro(244) and Leu(280) within the 4.1/
ezrin/
radixin/
moesin domain. The identification of this novel DAL-1/
Protein 4.1B-interacting
protein represents the first step towards elucidating its potentially unique mechanism of action.